Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 August 2021 | Story Ruan Bruwer | Photo Roger Sedres (Gallo Images)
Louzanne Coetzee and her guide Estean Badenhorst won the silver medal in the 1 500 m in a new African time at the Paralympics in Tokyo on Monday.

It’s been eight years of waiting, but Louzanne Coetzee will finally hang a medal around her neck, and this on the biggest sporting stage in the world.

Coetzee won the silver medal in the 1 500 m women’s T11 final at the Paralympics in Tokyo on Monday (30 August 2021) morning. In the process, she and her guide, Estean Badenhorst, set a new African record (4:40.96).

They are both former University of the Free State (UFS) students, and Coetzee is a resident on the Bloemfontein Campus. 

“I have been competing for eight years and this is my first medal. I’m just overwhelmed. I couldn’t have asked for a better race, a better guide, and better preparation. I’m just very thankful for how everything went down,” Coetzee said.
The race took place at 32 degrees with a humidity percentage of 70 plus. Coetzee’s time was only 2.04 seconds off the previous world record. 

She has had a stunning Games so far. In Sunday’s heat, she improved her personal best from 4:51.65 to 4:49.24 and ran another eight seconds quicker on Monday.

It was also a personal triumph for Coetzee, who experienced the disappointment of being disqualified five years ago at the Rio Games, after a ruling that her guide had stepped in front of her. 

Prof Francis Petersen, UFS Rector and Vice-Chancellor, saluted Coetzee. “We are tremendously proud of what she has achieved throughout her athletics career. She has represented the country numerous times at international sport events and winning a silver medal and setting a new African record is the culmination of hard work and exceptional endurance.” 

“The entire university community was rooting for her; she has done us and her country extremely proud,” Prof Petersen said.

Coetzee still has the T12 marathon on Sunday on her schedule.

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept